Korro and Tevard outlined approaches designed to expand the therapeutic use of RNA medicines beyond protein silencing, highlighting programs that aim to repair genetic defects or restore production of ...
A laboratory proof of concept shows that engineered plants can release a noncanonical amino acid that activates selected ...
Na terça-feira, 20 de outubro de 2026, a Korro Bio (CAMP) utilizou o 10º Healthcare Conference Anual da Chardan para detalhar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results